INTERVENTIONALCOMPLETEDNCT00123201

A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in the Acute Treatment of Migraine Headache

The primary objective of this study is to evaluate the efficacy and safety of dronabinol MDI for the acute treatment of moderate to severe migraine headache.

Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2015-01-16

What this record can show

Protocol only - no registry results posted

This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.

Registry facts

Study at a glance

Phase: PHASE2
Enrollment: Not reported
Start date: 2005-09
Sponsor: Solvay Pharmaceuticals
Design: RANDOMIZED · PARALLEL · TREATMENT
Locations: 29
Results record: Not present in registry snapshot

Linked local records

Related local records

Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.

Interventions

What was registered

DRUG

Dronabinol MDI

Eligibility

Population and criteria

Sex: ALL
Minimum age: 18 Years
Maximum age: 65 Years
Healthy volunteers: Not accepted

Inclusion criteria

Male or female subjects 18 to 65 years, inclusive, with clinically diagnosed migraine with or without aura based on International Headache Society criteria

Exclusion criteria

Subjects who experience migraine with prolonged aura; familiar hemiplegic migraine; migrainous infarction or basilar migraine; and those with greater than eight migraine attacks per month and/or greater than 14 migraine days per month.

Publications

Locally readable linked articles

No exact PMID-linked public article is currently readable locally.

Snapshot provenance

Snapshot: 64c4b220-ecd2-4945-ac95-e407e128e9a1
Retrieved: 11/09/2026, 14:54:28
SHA-256: 70d81f4c68edac6cd4f572a2c045d0f5e5811e0e82b46035e91ff526e0aed4fe

Protocol only - no registry results posted

Study at a glance

Related local records

Conditions

Cannabinoids and active compounds

Medicines